Non-late-onset neutropaenia following treatment of multiple sclerosis with ocrelizumab. Alba Suarez EM, Tallon Barranco A, Puertas Munoz I, Chamorro Hernandez B, et al. Neurologia 2021 Mar 13. pii: S0213-4853(21)00026.

Read + Share

Amedeo Smart

Independent Medical Education

Alba Suarez EM, Tallon Barranco A, Puertas Munoz I, Chamorro Hernandez B, et al. Non-late-onset neutropaenia following treatment of multiple sclerosis with ocrelizumab. Neurologia 2021 Mar 13. pii: S0213-4853(21)00026.
PMID: 33726971